Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China · Delayed Price · Currency is CNY 6.11
+0.03 (0.49%)
Sep 30, 2026, 3:04 PM CST
SHE:000153 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,502 | 3,858 | 4,285 | 4,275 | 4,004 | 3,652 |
Revenue Growth | -12.52% | -9.95% | 0.21% | 6.78% | 9.63% | 9.97% |
Gross Profit Gross Profit Growth | 662.71 | 699.15 | 927.3 | 1,091 | 1,119 | 1,081 |
Operating Income Operating Income Growth | 97.07 | 130.61 | 171.91 | 193.62 | 169.83 | 156.05 |
Net Income Net Income Growth | 94.42 | 99.42 | 160.83 | 159.29 | 154.43 | 122.98 |
Earnings Per Share EPS Growth | 0.20 | 0.21 | 0.35 | 0.34 | 0.35 | 0.28 |
EPS Growth | -31.03% | -38.20% | 1.02% | -1.49% | 23.60% | 18.53% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 1,442 | 1,505 | 1,999 | 2,586 | 2,263 | 1,841 |
Drug Retail Distribution Drug Retail Distribution Growth | 1,909 | 2,218 | 2,132 | 1,590 | 1,668 | 1,762 |
Unallocated Others Unallocated Others Growth | 150.67 | 135.43 | 154.28 | 98.88 | 73.24 | 49.3 |
Total Total Growth | 3,502 | 3,858 | 4,285 | 4,275 | 4,004 | 3,652 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 480.23 | 386.96 | 250.82 | 319.91 | 433.83 | 282.98 |
Total Debt Total Debt Growth | 1,512 | 1,087 | 984.67 | 687.76 | 737.34 | 625.93 |
Net Cash (Debt) Net Cash Growth | -1,032 | -700.51 | -733.85 | -367.86 | -303.51 | -342.95 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.22 | -1.51 | -1.58 | -0.79 | -0.68 | -0.78 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 174.83 | 119.3 | 126.24 | 254.75 | 439.99 | 264.62 |
Capital Expenditures CapEx Growth | -126.31 | -220.61 | -144.02 | -152.12 | -81.76 | -159.84 |
Free Cash Flow Free Cash Flow Growth | 48.52 | -101.31 | -17.78 | 102.64 | 358.23 | 104.78 |
Free Cash Flow Growth | - | - | - | -71.35% | 241.90% | 2.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 18.92% | 18.12% | 21.64% | 25.51% | 27.95% | 29.59% |
Operating Margin | 2.77% | 3.38% | 4.01% | 4.53% | 4.24% | 4.27% |
Pretax Margin | 3.18% | 3.24% | 4.87% | 5.03% | 5.05% | 4.38% |
Profit Margin | 2.70% | 2.58% | 3.75% | 3.73% | 3.86% | 3.37% |
FCF Margin | 1.39% | -2.63% | -0.41% | 2.40% | 8.95% | 2.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.107 | 0.071 | 0.071 |
Dividend Per Share Growth | 0% | 0% | -6.63% | 50.00% | 0% | - |
Dividend Yield | 1.64% | 1.63% | 1.69% | 1.69% | 0.79% | 0.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 30.07 | 29.31 | 17.71 | 19.53 | 29.16 | 30.41 |
Forward PE | - | 30.50 | 30.50 | 30.50 | 30.50 | 30.50 |
P/FCF Ratio | 58.52 | - | - | 30.31 | 12.57 | 35.69 |
PS Ratio | 0.81 | 0.76 | 0.67 | 0.73 | 1.13 | 1.02 |